Khan Asif M, Miotto Olivo, Heiny A T, Salmon Jerome, Srinivasan K N, Nascimento Eduardo J M, Marques Ernesto T A, Brusic Vladimir, Tan Tin Wee, August J Thomas
Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117597, Singapore.
Cell Immunol. 2006 Dec;244(2):141-7. doi: 10.1016/j.cellimm.2007.02.005. Epub 2007 Apr 16.
Epitope-based vaccines provide a new strategy for prophylactic and therapeutic application of pathogen-specific immunity. A critical requirement of this strategy is the identification and selection of T-cell epitopes that act as vaccine targets. This study describes current methodologies for the selection process, with dengue virus as a model system. A combination of publicly available bioinformatics algorithms and computational tools are used to screen and select antigen sequences as potential T-cell epitopes of supertype human leukocyte antigen (HLA) alleles. The selected sequences are tested for biological function by their activation of T-cells of HLA transgenic mice and of pathogen infected subjects. This approach provides an experimental basis for the design of pathogen specific, T-cell epitope-based vaccines that are targeted to majority of the genetic variants of the pathogen, and are effective for a broad range of differences in human leukocyte antigens among the global human population.
基于表位的疫苗为病原体特异性免疫的预防和治疗应用提供了一种新策略。该策略的一个关键要求是识别和选择作为疫苗靶点的T细胞表位。本研究以登革热病毒为模型系统,描述了当前选择过程的方法。结合公开可用的生物信息学算法和计算工具,筛选和选择抗原序列作为超型人类白细胞抗原(HLA)等位基因的潜在T细胞表位。通过所选序列对HLA转基因小鼠和病原体感染受试者的T细胞的激活作用来测试其生物学功能。这种方法为设计针对病原体大多数基因变体、对全球人群中广泛的人类白细胞抗原差异有效的病原体特异性、基于T细胞表位的疫苗提供了实验基础。